Cyril Alkis Konto

Title: Cyril Alkis Konto: Innovator in Chimeric Antigen Receptor T Cell Therapy

Introduction

Cyril Alkis Konto is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of immunotherapy, particularly in the development of methods for administering chimeric antigen receptor (CAR) T cells. His work is crucial for advancing treatments for diseases such as cancer.

Latest Patents

Cyril Alkis Konto holds a patent titled "Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells." This patent focuses on dosages for the treatment of human patients who are susceptible to or diagnosed with diseases like cancer. The disclosure includes methods for administering CAR-T cells, as well as compositions and articles of manufacture for use in these methods. He has 1 patent to his name.

Career Highlights

Throughout his career, Konto has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Allogene Therapeutics, Inc. and Les Laboratoires Servier. His experience in these organizations has allowed him to contribute to groundbreaking advancements in cancer treatment.

Collaborations

Cyril Alkis Konto has collaborated with various professionals in his field. One of his notable coworkers is Amina Zinai, with whom he has worked on innovative projects related to CAR-T cell therapies.

Conclusion

Cyril Alkis Konto is a pioneering inventor whose work in CAR-T cell therapy is making a significant impact in the fight against cancer. His contributions through patents and collaborations continue to shape the future of immunotherapy.